Cove Fund

Cove Fund is a venture capital firm based in Irvine, California, established in 2014. It specializes in providing seed-stage funding to early-stage technology and life science companies located in Southern California. The firm focuses on investing in promising startups that have the potential to develop differentiated products and services, aiming to create significant value through their initial investments. By targeting innovative ventures, Cove Fund seeks to support companies that are poised for impactful growth in their respective markets.

Steve Petilli

Venture Partner

Paul Voois

Fund Manager

J.C. Ruffalo

Venture Partner

Past deals in 3D Printing

BLNG

Seed Round in 2025
BLNG is a generative AI company focused on the jewelry industry, offering innovative design software and data products. The company provides AI-powered tools that empower creators to design personalized jewelry, fostering a transformative experience that encourages creativity and meaningful connections with jewelry. By leveraging AI-driven design, BLNG enables businesses to explore new possibilities in customization and innovation, shaping the future of personalized jewelry.

Carlsmed

Series B in 2022
Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

Carlsmed

Series A in 2020
Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

Carlsmed

Seed Round in 2020
Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

icClarity

Seed Round in 2016
icClarity, Inc. specializes in developing advanced 3-dimensional image capturing solutions, featuring a single imager, an illumination source, and an efficient firmware stack that processes raw sensor data to produce usable 3D coordinates. Founded in May 2014 and based in Irvine, California, the company addresses the growing demand for high-resolution 3D image capture without the computational burdens associated with traditional multi-sensor systems. Its patented technology is applicable across various sectors, including security and surveillance, automotive, gaming, webcams, medical devices, and smartphones. As of now, icClarity is in the final stages of producing its first mass-production device, with expectations to begin shipping soon.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.